Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical technology company, continues to drive progress in chronic wound management with an industry-leading portfolio set to showcase at the upcoming European Wound Management Association (EWMA) Conference, Bremen between 6-8 May 2026.
Demonstrating a long-term commitment to chronic wound management, Smith+Nephew is launching two new wound care innovations designed to support patient outcomes, simplify wound management and ease the clinical burden. This reflects the scale and urgency of a challenge that affects up to 14.9m people in Europe and consumes up to 4% of healthcare spend1. Fully supporting clinicians and patients across the continuum of care, these purpose-built products are set to take on the challenge of chronic wounds, drive better clinical outcomes and get patients back to what they love.
ALLEVYN♢ COMPLETE CARE Foam Dressing has a unique five-layer construction with distinct mode of action capabilities targeted towards both wound management and pressure ulcer prevention. Enhanced ExuLOCK♢ Technology helps lock in exudate and bacteria, releasing up to 100 times fewer bacteria than other foam dressings*. A unique ExuMASK♢ Change Indicator adds confidence to wound healing by minimising strikethrough and is proven to result in longer wear times than other foam dressings, while advanced ShearDEFENSE♢ Unbonded Layer Technology is designed to protect from pressure injuries by dissipating shear forces.
RENASYS♢ EDGE Negative Pressure Wound Therapy System is designed with simplicity at its core. Prioritising effectiveness, intuition and patient discretion, the lightweight pump supports portability and convenience, significantly improves wound outcomes** and results in an average of 88% therapy session patient compliance. The modular system's low-cost maintenance functionality removes annual servicing requirements while the intentional design supports patient self-care.
Login to comment